Cannalink, Inc.

Cannalink, Inc.

CNLK
Cannalink, Inc.US flagOther OTC
0.00
USD
- -
- -
No data availableFinancial data will appear here once available

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Company Description

APIChat
CEO
Richard Smith
Sector
Technology
Industry
Information Technology Services
Address
110 West C Street San Diego CA United States of America 92101
IPO Date
Aug 25, 1998
Business
Cannalink, Inc. (CNLK) operates as a development-stage company focused on the cannabis industry, primarily providing web development and graphic design services tailored to cannabis-related businesses; it also intends to develop cannabidiol (CBD)-based products, including sublingual formulations like those derived from the acquired MigraSpray technology for migraine treatment and potential healthcare distribution. The company offers specialized website design for marijuana enterprises and business consulting, merchant banking, and investment services targeting emerging medical marijuana and industrial hemp companies. Its services emphasize digital solutions for the cannabis sector, with historical involvement in joint ventures such as Hempwire, LLC. Founded on August 29, 1997, and headquartered at 110 West C Street, Suite 1300, San Diego, California 92101, United States, Cannalink previously operated under the name Superwire, Inc. prior to a significant name change and 1-for-50 reverse stock split in September 2014, alongside the $300,000 acquisition of the MigraSpray product line and assets to support CBD product development. The company maintains a presence on OTC Pink Sheets (OTCPK) since June 1998 and targets healthcare practitioners, cannabis operators, and emerging firms in the pharmaceuticals, biotech, and specialty telecommunications segments. No recent partnerships, funding rounds, acquisitions, or product launches within the last 1-2 years are publicly reported, reflecting its current development-stage status with limited operational disclosures.